معرفی
Inhye Park is a Novo Nordisk Postdoctoral Research Fellow at the Kennedy Institute of Rheumatology, University of Oxford. She completed her DPhil in Molecular and Cellular Medicine at Oxford (2019) after obtaining a Master's in Biomedicine from University College London. Her research investigates macrophage functions in cardiometabolic diseases using single-cell transcriptomics and iPSC-derived models.
Research interests include:
- Immunometabolic regulation in atherosclerosis
- CLEC receptor signaling in vascular inflammation
- Single-cell analysis of immune cell heterogeneity
- Precision medicine approaches for cardiovascular disease
Her publications focus on macrophage heterogeneity in vascular inflammation, with recent work extending to COVID-19 immunopathology. Major contributions include identifying CLEC4A2 as a key regulator of macrophage homeostasis in atherosclerosis.
Fellowships:
- Novo Nordisk Postdoctoral Research Fellowship
۰مقاله منتشرشده